173 related articles for article (PubMed ID: 16006997)
1. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair.
Landi S; Gemignani F; Gioia-Patricola L; Chabrier A; Canzian F
Biotechniques; 2003 Oct; 35(4):816-20, 822, 824-7. PubMed ID: 14579748
[TBL] [Abstract][Full Text] [Related]
4. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.
Gemignani F; Landi S; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Gaborieau V; Gioia-Patricola L; Bellini I; Barale R; Canzian F; Hall J; Boffetta P; Hung RJ; Brennan P
Carcinogenesis; 2007 Jun; 28(6):1287-93. PubMed ID: 17259654
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Özhan G; Mutur M; Ercan G; Alpertunga B
Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
Kiyohara C
J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
[TBL] [Abstract][Full Text] [Related]
9. [A case-control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer].
Chen K; Jin MJ; Fan CH; Song L; Jiang QT; Yu WP; Ma XY; Yao KY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):659-64. PubMed ID: 16471212
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
12. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples.
Yoshimura K; Hanaoka T; Ohnami S; Ohnami S; Kohno T; Liu Y; Yoshida T; Sakamoto H; Tsugane S
J Hum Genet; 2003; 48(12):654-658. PubMed ID: 14634838
[TBL] [Abstract][Full Text] [Related]
13. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.
Pande M; Amos CI; Eng C; Frazier ML
Mol Carcinog; 2010 Nov; 49(11):974-80. PubMed ID: 20886582
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
16. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: A retrospective cohort study in Taiwan.
Kamiza AB; You JF; Wang WC; Tang R; Chang CY; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
Environ Mol Mutagen; 2018 Jan; 59(1):69-78. PubMed ID: 28714190
[TBL] [Abstract][Full Text] [Related]
18. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
[TBL] [Abstract][Full Text] [Related]
19.
Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
[TBL] [Abstract][Full Text] [Related]
20. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.
Hlavata I; Vrana D; Smerhovsky Z; Pardini B; Naccarati A; Vodicka P; Novotny J; Mohelnikova-Duchonova B; Soucek P
Oncol Rep; 2010 Nov; 24(5):1347-53. PubMed ID: 20878130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]